Suff wrote:I suspect that a vaccine, even with a 25% success rate, may be deployed regardless of issues.
Yes, I suspect that is why AstraZeneca are ramping up production of one version.
My son works in the same Oxford lab as the girl who had the very first jab of the potential vaccine trial back in April. It's a double blind trial so nobody knows who got the vaccine and who got a placebo. They are regularly tested and though the results are kept secret from the volunteers they are all doing well.
Recruitment has now been done for another 10,260 volunteers in phase 2 for the age ranges 5-12, 56-69 and over 70 and that suggests that there could be some positive news come August(ish). They would not start without some level of confidence.
When phase 3 starts it will be a much larger group of over 18s and they will get either the new vaccine or a licensed vaccine, I think for meningitis, and if that goes well then who knows?
On top of that is the news that an old and cheap drug, dexamethasone, cuts the death rate for those on ventilators by a third and those on oxygen by a fifth.